Vesta Director Sells $203,000 Stock as Shares Jump 25%
A Vesta director recently sold roughly $203,000 worth of stock while the company’s shares have risen about 25% over t...
Wealth building strategies vary by income level. Discover tailored approaches that align with your financial circumstances for better results.
23,860 articlesA Vesta director recently sold roughly $203,000 worth of stock while the company’s shares have risen about 25% over t...
As 2026 unfolds, investors face a clear choice between Lilly's growth engine in big markets and Teva's value-forward ...
Memory plays a critical role in AI growth, and micron's data center gross margin has surged to industry-leading level...
A Detroit autoworker’s dream of winning margins meets a global market that’s increasingly dependent on China. This ar...
The Australian government is considering changes to the 50% capital gains discount for assets held over a year, a mov...
ai healthcare news is accelerating how we diagnose, treat, and manage care. This guide breaks down the trends, how to...
Poet Technologies stock sold off again as investors weigh dilution, growth prospects, and market jitters. This analys...
Mesirow Financial Investment Management revealed a substantial new holding in the Akre Focus ETF. This piece explains...
The Lego Foundation unveils a five-year, $97 million plan with the International Rescue Committee to bring play-based...
When conviction runs hot but capital is capped, traditional 1:1 bets may feel limiting. The forget returns: double-le...
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Nvidia’s Feb 25 earnings print could set the stock’s direction for months. This preview breaks down the numbers to wa...